Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis.
Introducing demographic corrections for the 10/36 Spatial Recall Test.
Developing a therapeutic plan for treating MS: evidence for new treatments.
Teva and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO Trial
Long-term effects of fingolimod in multiple sclerosis: The randomized FREEDOMS extension trial.
Helminth therapy or elimination: epidemiological, immunological, and clinical considerations.
Inflammation high-field magnetic resonance imaging.
Factors associated with the effectiveness of plasma exchange for the treatment of NMO-IgG-positive neuromyelitis optica spectrum disorders.
Brain-Derived Neurotrophic Factor in Neuroimmunology: Lessons Learned from Multiple Sclerosis Patients and Experimental Autoimmune Encephalomyelitis Models.
The discovery of natalizumab, a potent therapeutic for multiple sclerosis.
Delayed Central Nervous System Irradiation Effects in Rats - Part 2: Aggravation of Experimental Autoimmune Encephalomyelitis.
PML in MS Patients Making Natalizumab-to-Fingolimod Switch
Improvement in Fatigue during Natalizumab Treatment is Linked to Improvement in Depression and Day-Time Sleepiness.
The pathogenic role of the inflammasome in neurodegenerative diseases.
The spectrum of post-vaccination inflammatory CNS demyelinating syndromes.
Is it useful to perform carbon monoxide diffusion capacity and respiratory muscle function tests in patients with multiple sclerosis without disability?
K(+) channel alterations in the progression of experimental autoimmune encephalomyelitis.
Strength-duration time constant in peripheral nerve: no abnormality in multiple sclerosis.
MRI correlates of disability in african-americans with multiple sclerosis.
Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.
Cortical Pathology in RRMS: Taking a Cue from Four Sisters.
Cross-cultural adaptation and validation of the 12-item Multiple Sclerosis Walking Scale (MSWS-12) for the Brazilian population.
Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation.
Review of Animal Models of Neuromyelitis Optica.
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex.
Pages
« first
‹ previous
…
230
231
232
233
234
235
236
237
238
…
next ›
last »